Navigation Links
The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health
Date:7/25/2008

ncrease their searches for new applicants in June. Only New Jersey -- 7.8 percent -- and California -- 2.2 percent -- showed significant downswings in resume searches. Sales representative searches were up by 2.2 percent overall, but nursing was the opening most employers wanted to fill -- 2.4 percent of resume searches on MedZilla.com were for nurses. Research also showed a small percentage of growth. Meanwhile, management position searches fell by 2.4 percent in June, reflecting the trend in outplacement reports that stresses streamlining of supervisory tasks.

Employers who were not actively searching for new applicants nevertheless continued posting job openings, most notably in primary care and office positions, with 3.8 percent availability growth in that area. Sales postings went up by 2.2 percent, and marketing or business development by 4 percent, possibly indicating that some companies foresee receiving regulatory approval from the FDA and, therefore, the need to market and sell new drugs. "Companies could be hedging their bets there," Hopps said, "hoping to have personnel in place when it's time to make their move."

As in the previous months, potential applicants continued showing caution at the prospect of changing jobs. Despite the vast growth in ambulatory health care jobs, and even though there were fewer jobs created in June than in May, job seeker numbers changed relatively little through June. Even the number of individuals searching for sales positions was off from previous months; in June, sales searches only grew by 1.1 percent, instead of the two-plus percentage seen through most of the last year. In mid-July, the Associated Press reported that PhRMA, Pharmaceutical Research and Manufacturers of America, revised their conduct code for sales representatives when dealing with health care professionals, creating stricter rules for what kinds of free items representatives can give out, and those new rul
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. The MedZilla Report: May 2008 Employment Outlook for Biotech/Pharma/Health
2. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
3. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
4. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
5. New report: private/public insurance mix is most practical way to achieve universal coverage
6. New Report: Increasing Marylands Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
7. Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit
8. Landmark Report: Excess Body Fat Causes Cancer
9. New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking
10. Report: Too Few Physicians, Nurses to Implement Presidential Candidates Health Reform Plans
11. American Heart Association Themed Issue Journal Report: Journal Edition Dedicated to Womens Unique Hypertension Issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health
The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health
(Date:9/4/2008)...ptember 5, 2008Private Medicare Advantage (MA) pla...nrollee in 2008 compared to what the same enrollee...or-service program, according to a new report from...tions to MA plans mandated by the Medicare Improve...A) scheduled to take effect beginning in 2010 ha...
(Date:9/4/2008)...ence of instructions they say could help doctors e...lthDay News) -- Vaccine safety experts say that al...eive vaccinations with close monitoring and a set ...ptember issue of Pediatrics , a team of experts l...h a step-by-step set of instructions -- an algorit...
(Date:9/4/2008)... Medelis, an oncology contract research organ...linical Trials: A Nuanced Approach to Get Into the...cGarry, a preclinical research scientist with 35 y...ical studies are commonly viewed as straightforwar...o operate without true integration with preclinica...
(Date:9/4/2008)... of Palestinian and Israeli teenagers, art from,Ar...wire/ -- America must take a major,role in finding...he world,says Ira Magaziner, chair of the William...ior White House Advisor for Policy Development in ...e speaker at a conference at,Massachusetts School ...
Breaking Medicine News(10 mins):Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 2Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 4
...m the university of Michigan state that Women who ...more likely than nonsmokers to give birth// to a b...rth defect rises with the number of cigarettes tha...ors like the mother's race, age and educational le...
...gthening drug fosamax (Bifosa) was initially laude...sis. But doctors discovered that patients often st...igid dosing instructions: It was supposed to be ta...ed with plenty of water. To top it off, the drug c...
...nsity lipoprotein(LPD), lipid composition and anti...liability to oxidation of LDL derived from diabeti...re the oxidation of LDL drawn from patients with d... also sought to follow-up the effects of dietary b...
...hat women have yet another good reason to exercise...for so many things. It reduces our risk of heart d...s levels. Now a new study says it's also good for ... Right now screening tests for ovarian cancer are ...
Other Medicine News:
(Date:9/4/2008)... Data for Ipilimumab to be Presented, PRINCETON, ...nc.,(Nasdaq: MEDX ) announced today that nine cli... anti-CTLA-4 antibody, in melanoma are scheduled t...ress of the European Society,for Medical Oncology ...lm.,Many of the following abstracts will include u...
(Date:9/4/2008)... on Schedule with Two Abstracts Accepted for P...vember 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswi... pharmaceutical company focused on the treatment o...unced the appointment of,Peter L. Garrambone, Jr. ...mbone,s career includes more than 50 pharmaceutica...
(Date:9/3/2008).../- Simcere,Pharmaceutical G...plier of,branded generic pharmaceuticals and manuf...t Endu (also known as Endostar) in China,announce...udy., At the request of the SFDA, Simcere initiat...he safety and therapeutic efficacy of Endu, a modi...
(Date:9/3/2008)...onal Vascular Disease Awareness Month, CHARLOTTES...maceuticals,LLC, a clinical-stage drug-development...nt of unmet medical needs, announced today that it...ical trial of its lead drug,candidate trans sodium...881,on the clinicaltrials.gov Website, is investig...
Breaking Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 8672 1Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 8672 2Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 8672 3How to Survive an Unexpected Trip to the Hospital During Christmas and New Years 8668 1How to Survive an Unexpected Trip to the Hospital During Christmas and New Years 8668 2Indevus Comments on Bayer Healthcare Discontinuation of Viadur 28R 29 2352 1Indevus Comments on Bayer Healthcare Discontinuation of Viadur 28R 29 2352 2Indevus Comments on Bayer Healthcare Discontinuation of Viadur 28R 29 2352 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2348 1VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2348 2VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2348 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2348 4
...rstCall/ -- CEL-SCI,CORPORATION announces that CEL...an influenza antigen in combination with MAS-1, a,...ngs were,presented on May 23, 2007 by Dr. Daniel Z...lar Immunology at CEL-SCI at the,American Society ...,Toronto, Canada. , This new finding with CEL-1000...
...tCall/ -- Shire plc,announced today that DAYTRANA(...ntion Deficit Hyperactivity Disorder (ADHD) patch,... of ADHD in both,male and female children aged 6 t...ported at the American Psychiatric Association,(AP...udies have examined gender differences in the,resp...
Other Medicine Technology:CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response,Against Avian Flu Antigen in Animals 2Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 2Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 3Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 4Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 5Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 6Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 7Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 8
...nts with,predominantly classic subfoveal choroid... the Opal Photoactivator from,Lumenis. Developed...or injection) therapy, the Opal Photoactivator,o...tures,that ensure the highest level of patient c...
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: